Pfizer (NYSE:PFE) - Page 2

Pfizer

Are Pfizer’s Acquisitions Holding Back Its Bottom Line?

Pfizer Inc. (NYSE: PFE) reported its fourth-quarter financial results before the markets opened on Tuesday. The company posted $0.47 in earnings per share (EPS) and $13.63 billion in revenue. Thomson ...
Read Full Story »
100 dollar bills

Top 7 Earnings Reports to Look For Tuesday

As January is coming to a close, the fourth-quarter earnings season is beginning to slow, but it's not over yet. 24/7 Wall St. has put together a preview of some of ...
Read Full Story »
Profit or Loss

What to Expect From Dow Stocks Reporting This Week

24/7 Wall St. has put together a preview of the Dow Jones Industrial Average companies scheduled to report their quarterly results this week. Five of the Dow stocks are reporting next ...
Read Full Story »
Prescription drugs

Short Sellers Run for Cover From Major Pharma

Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »
ThinkstockPhotos-464526524

5 Worst Performing Dow Stocks of 2017

Even though the new year is barely three weeks old, it's not too soon to take a look at how the 30 blue chip stocks included in the Dow Jones Industrial ...
Read Full Story »
market crash

Exxon Mobil, Merck Weigh on DJIA Thursday

January 19, 2017: Markets opened slightly higher Thursday as investors appear to be waiting to what President-elect Donald Trump has to say in his inauguration speech on Friday. Only the industrials ...
Read Full Story »
market crash

JPMorgan, Goldman Sachs Sink DJIA on Tuesday

January 17, 2017: Markets opened lower Tuesday as financial stocks took a severe beating in the session following remarks by the president-elect that he wanted a weaker dollar. That sent ...
Read Full Story »
market crash

Disney, Microsoft Lead DJIA Drop Thursday

January 12, 2017: Markets opened lower Thursday and politics -- or the lack of policy -- gets the blame following President-elect Donald Trump's press conference that failed to have anything ...
Read Full Story »
Prescription drugs

Major Pharma Short Interest Declines Ahead of Trump Comments

The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
100 dollar bills

Wednesday’s Top Biopharma Movers

Biotech and pharma companies were on the move Wednesday. A few of the smaller caps made tremendous gains on the day, while a couple of the major firms saw massive ...
Read Full Story »
Prescription drugs

2017 Bull-Bear Case for Health Care: J&J, Merck, Pfizer, UnitedHealth

Major Dow Jones Industrial Average companies in the health care sector saw a relatively strong 2016, with most posting a solid gain on the year. One of these stocks was ...
Read Full Story »
Dog Barking 2

Meet the 2017 Dogs of the Dow: Massive Dividends and Expected Upside

The year 2016 went out with a bang for stock investors after large November and December post-election rallying. Closing at 19,762.60 on December 30, the Dow Jones Industrial Average may ...
Read Full Story »
graph

Beyond DJIA 20,000: What Could Drive the Dow to 22,000 in 2017

With 2016 winding down, some investors are looking backward to see what worked and what did not. With a 14% rally in the Dow Jones Industrial Average (DJIA) this year, ...
Read Full Story »
Dow

5 Companies That Will Kill the Dow’s Move to 20,000

Most of the 30 components of the Dow Jones Industrial Average have risen by double-digit percentages this year. Five are up over 30%. These double-digit stocks have helped push the ...
Read Full Story »
Prescription drugs

Short Interest Rises in Major Pharma

The short interest data have been released for the December 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »